Zweig-DiMenna Associates’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Zweig-DiMenna Associates’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-83,500	Closed	-$4.71M	–	296
2015 Q3	$4.71M	Buy	+83,500	New	+$5.41M	0.2%	104
2015 Q2	–	Sell	-77,490	Closed	-$4.83M	–	316
2015 Q1	$4.83M	Buy	77,490 +4,000	+5%	+$233K	0.2%	110
2014 Q4	$4.23M	Buy	+73,490	New	+$4.09M	0.18%	120

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Zweig-DiMenna Associates's TEVA Position: Q4 2015 in Review

Zweig-DiMenna Associates sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2015, closing a stake of 83,500 shares — an estimated $4.71M sold.

Zweig-DiMenna Associates first reported a position in TEVA in Q4 2014 and held it in 3 quarters. The position peaked at $4.83M in Q1 2015. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Zweig-DiMenna Associates reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2015 after selling out during the quarter.
Zweig-DiMenna Associates sold 83,500 Teva Pharmaceutical Industries Limited shares in Q4 2015, an estimated $4.71M.
Zweig-DiMenna Associates first reported a position in Teva Pharmaceutical Industries Limited in Q4 2014 and held it in 3 quarters.
Zweig-DiMenna Associates's Teva Pharmaceutical Industries Limited position peaked at $4.83M in Q1 2015.
877 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2015.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2015, filed 10 Feb 2016.